The global Clinical Trial Supplies market is witnessing steady expansion as pharmaceutical and biopharmaceutical companies increase research and development activities and the number of clinical trials continues to grow. Rising drug development costs and the increasing prevalence of chronic diseases are contributing to demand for efficient clinical trial supplies management. Clinical trial...
The Global Vinca Alkaloid Market is witnessing steady growth, driven by the increasing use of plant-derived alkaloids in cancer treatment and the continued development of oncology therapeutics. Vinca alkaloids are an important class of antineoplastic agents used in chemotherapy, particularly for treating various hematological malignancies and solid tumors. Their established role in cancer care...
The global Cell and Gene Therapy Market is expanding as pharmaceutical and biotechnology companies increase their focus on advanced treatments for chronic diseases, genetic disorders, oncology, rare diseases, and personalized medicine. Increasing research activity, biotechnology investments, regulatory support, and technological innovation are contributing to the development and adoption of...
Polaris Market Research has published its latest research report titled Curling Irons Market Size, Share & Opportunity Report, 2025–2034. The report examines the global Curling Irons Market, covering its current size, market share, growth prospects, and industry developments. It discusses the factors influencing demand and provides an overview of the changes taking place across the...
The global Injectable Drug Delivery Market is witnessing steady expansion as injectable therapies become increasingly important across chronic diseases, acute conditions, and emergency care. The market size is projected to reach 84.08 billion by 2031 from 48.89 billion in 2024, registering a CAGR of 8.2% during 2025–2031. The growth reflects increasing demand for injectable therapies, the...
The global High Content Screening Market is experiencing significant growth as pharmaceutical companies, biotechnology organizations, and research institutions increasingly focus on advanced drug discovery and cellular analysis technologies. The market was valued at US$ 764.40 million in 2025 and is projected to reach US$ 1,642.20 million by 2034, registering a compound annual growth rate of...
The Global Nucleic Acid Isolation and Purification Market is experiencing steady expansion as molecular biology, genomics, biotechnology, and clinical diagnostics continue to advance. Nucleic acid isolation and purification are essential laboratory processes used to extract DNA and RNA from biological samples while removing contaminants that may interfere with downstream applications. These...
The global epigenetics market is experiencing significant growth as advancements in genomic research, increasing cancer prevalence, and the expanding adoption of personalized medicine create new opportunities across healthcare and biotechnology industries. The epigenetics market size is projected to reach US$ 35.84 billion by 2031 from US$ 11.12 billion in 2024. The market is expected to...
The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Gemcitabine Hydrochloride market was valued at US$ 873.1 million in 2025 and is expected to reach US$ 1,297.83 million by 2034. The market is estimated to record a CAGR of 4.5% during 2026–2034. The increasing prevalence of cancer, rising demand for effective chemotherapy medications, growing awareness of early cancer diagnosis, and expanding access to oncology treatments are among...
The Global Specialty Pharmaceuticals Market size is projected to reach US$ 2,334.45 billion by 2034 from US$ 293.84 billion in 2025. The market is anticipated to register a CAGR of 25.90% during the forecast period 2026–2034. The growing prevalence of chronic and rare diseases, increasing demand for advanced biologic therapies, rising investments in pharmaceutical research and...
The Global Veterinary Imaging Market was valued at US$ 2.22 billion in 2024 and is expected to reach US$ 3.54 billion by 2031, registering a compound annual growth rate (CAGR) of 6.9% from 2025 to 2031. Increasing demand for advanced animal healthcare services, rising pet ownership, and the growing use of diagnostic technologies are supporting the expansion of this industry. Veterinary imaging...
